GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (1x20)

GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (1x20)

GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (100x20)

GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (100x20)

GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (10x20)

The GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test is intended for the qualitative detection of SARS-CoV-2 antigens from nasopharyngeal samples within 15 minutes.

The tests show diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%, therefore they meet the WHO performance criteria (sensitivity ≥ 80%; specificity ≥ 97%) for use in the global fight against COVID-19.

The GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test is a double antibody-sandwich, qualitative membrane-based immunoassay. In-vitro diagnostic medical device. The kit is designed to detect nucleocapsid antigen from the SARS-CoV-2 in nasopharyngeal swabs from patients who are suspected of being COVID-19 positive.

Main Features

• Fast and reliable results in 15 minutes
• Sample material: nasopharyngeal swabs
• Cost-effective and easy to use; no additional special equipment required
• Transportation and storage at room temperature
• Diagnostic Sensitivity: 92.6% ; Diagnostic Specificity: 98.6%
• CE-IVD

Test Procedure

After sample collection, insert the swab into the tube containing the buffer solution. Rotate the swab for one
minute and close the lid. Use the dropper to transfer 3 drops (approximately 100 μL) of the specimen with
reagent to the specimen well (S) of the cassette, and start the timer.

More Information
SKU CVAG4940-10
Test principle Double antibody-sandwich, qualitative membrane-based immunoassay - In-vitro diagnostic medical device
Analysable samples Nasopharyngeal swabs
Assay time 15 min
No. of tests 10x20